173 related articles for article (PubMed ID: 27966208)
1. Puerarin and zinc additively prevent mandibular bone loss through inhibiting osteoclastogenesis in ovariectomized rats.
Liu H; Li W; Jia S; Li B
Histol Histopathol; 2017 Aug; 32(8):851-860. PubMed ID: 27966208
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of puerarin (low dose) and zinc attenuates bone loss and suppresses bone marrow adiposity in ovariectomized rats.
Liu H; Li W; Ge X; Jia S; Li B
Life Sci; 2016 Dec; 166():20-26. PubMed ID: 27697446
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats.
Liu X; Bao C; Xu HHK; Pan J; Hu J; Wang P; Luo E
Acta Biomater; 2016 Sep; 42():378-388. PubMed ID: 27318268
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
Mao L; Xia L; Chang J; Liu J; Jiang L; Wu C; Fang B
Acta Biomater; 2017 Oct; 61():217-232. PubMed ID: 28807800
[TBL] [Abstract][Full Text] [Related]
5. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
[TBL] [Abstract][Full Text] [Related]
6. Puerarin enhances bone mass by promoting osteoblastogenesis and slightly lowering bone marrow adiposity in ovariectomized rats.
Li B; Liu H; Jia S
Biol Pharm Bull; 2014; 37(12):1919-25. PubMed ID: 25590084
[TBL] [Abstract][Full Text] [Related]
7. Puerarin Stimulates Osteogenic Differentiation and Bone Formation Through the ERK1/2 and p38-MAPK Signaling Pathways.
Yang X; Yang Y; Zhou S; Gong X; Dai Q; Zhang P; Jiang L
Curr Mol Med; 2018 Mar; 17(7):488-496. PubMed ID: 29256352
[TBL] [Abstract][Full Text] [Related]
8. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
[TBL] [Abstract][Full Text] [Related]
9. Zinc enhances bone metabolism in ovariectomized rats and exerts anabolic osteoblastic/adipocytic marrow effects ex vivo.
Li B; Liu H; Jia S
Biol Trace Elem Res; 2015 Feb; 163(1-2):202-7. PubMed ID: 25431298
[TBL] [Abstract][Full Text] [Related]
10. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
11. Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-κB and stimulation of PI3K/AKT.
Liu J; Zhang Z; Guo Q; Dong Y; Zhao Q; Ma X
Phytomedicine; 2018 Mar; 42():43-50. PubMed ID: 29655696
[TBL] [Abstract][Full Text] [Related]
12. Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
Li H; Chen B; Pang G; Chen J; Xie J; Huang H
Pharm Biol; 2016; 54(1):111-7. PubMed ID: 25857587
[TBL] [Abstract][Full Text] [Related]
13. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats.
Zhou J; Chen S; Guo H; Xia L; Liu H; Qin Y; He C
Rheumatol Int; 2013 May; 33(5):1135-41. PubMed ID: 22948539
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
16. Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.
Wang Y; Huang P; Tang PF; Chan KM; Li G
J Orthop Surg Res; 2011 Jul; 6():34. PubMed ID: 21752290
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
[TBL] [Abstract][Full Text] [Related]
18. Puerarin decreases bone loss and collagen destruction in rats with ligature-induced periodontitis.
Yang X; Zhang H; Wang J; Zhang Z; Li C
J Periodontal Res; 2015 Dec; 50(6):748-57. PubMed ID: 25645818
[TBL] [Abstract][Full Text] [Related]
19. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
